# Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers

> **NCT01001988** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 596 (actual)

## Conditions studied

- Encephalitis
- Japanese Encephalitis

## Interventions

- **OTHER:** Blood sample
- **BIOLOGICAL:** JE-CV administered in Study JEC02

## Key facts

- **NCT ID:** NCT01001988
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08-07
- **Primary completion:** 2013-10-16
- **Final completion:** 2013-10-16
- **Target enrollment:** 596 (ACTUAL)
- **Last updated:** 2017-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01001988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01001988, "Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01001988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*